Study finds most cancer patients exposed to misinformation. Researchers pilot 'information prescription.'
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Nov-2025 13:11 ET (9-Nov-2025 18:11 GMT/UTC)
CAR T cells have revolutionized the treatment of certain blood cancers, but they often fail. A new study published in Nature (DOI: 10.1038/s41586-025-09507-9) by scientists at CeMM and the Medical University of Vienna introduces a novel CRISPR screening platform, which discovered unexpected genetic edits that make CAR T cells more effective as cancer therapies
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment — an immunotherapy that uses modified patient T cells to target cancer. The study used CRISPR screening to pinpoint genes that influenced T cell function and survival in culture and in a preclinical model of multiple myeloma. Their results and technique, published in Nature, could lead to T cell-based immunotherapies for cancer.
An international team of researchers led by Dr Manel Esteller, head of the Cancer Epigenetics Group at the Josep Carreras Leukaemia Research Institute, has just published the most comprehensive analysis to date of the longest-lived person ever recorded, the Catalan woman Maria Branyas, who passed away at the end of 2024 at the age of 117. The peer-reviewed study, published in the prestigious international journal Cell Reports Medicine, concludes that the biology of supercentenarians is more complex than previously thought, and that the key may lie in a delicate balance between opposing forces.